Introduction
In 2013 a group of international collaborators met to discuss what we know about the age and causes of death of people with intellectual disabilities (ID), the limitations of our existing data and how we could improve our knowledge in this respect. The collaboration has since been supported by a UK Economic and Social Research Council (ESRC) grant for a series of webinars and meetings from 2014 -2017 to bring together academics, practitioners and policy-makers to discuss the development of internationally comparable mortality data in relation to people with ID. In this Special Edition, some of the contributors to those discussions set out the best evidence we have to-date about mortality data relating to people with ID.
But first, let us review why an understanding of mortality data in general, and in relation to people with ID in particular, is such an important area of concern.
Surveillance of patterns of mortality in vital statistics Analysis of mortality data to improve the health of the population has a long history. In the UK, William Farr used mortality data in the 1850s to stimulate debate about why 3 some cities were less healthy than others (Szreter 1991) . At about the same time in the US, the first mortality report by the Massachusetts Sanitary Commission highlighted differences in age at death between farmers and mechanics, urging doctors to make more inquiries into the causes of death which prematurely shortened lives (Shattuck 1850) .
During the 19 th and 20 th centuries, as mortality data became available in industrialised countries, public health became transformed (Jha 2012) . Doll & Hill (1950) used mortality data to highlight a substantial increase in male deaths from lung cancer and hypothesised the causal association between smoking tobacco and lung cancer. In the US, Gottlieb et al. (1981) used routine mortality data from San Francisco to signal the start of the American HIV epidemic.
Reliable and timely information on cause-specific mortality has now become a fundamental component of evidencebased health policy development, implementation, and evaluation. In short, Jha (2012)  Standardised Mortality Ratio (SMR) -the ratio of deaths observed in a particular group to those expected in a reference population of identical age structure. This provides a measure of how many more deaths than expected (if the death rate in the general population were applied) are observed in the population of interest. SMRs can be compared over time, between sexes and with equivalent statistics for other countries.
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 Years of life lost -the total number of life years lost due to premature death. It is calculated by subtracting age at death from a threshold age, most commonly a threshold age for prematurity such as age 65 or 70, but the upper limit could also be life expectancy at birth or other variants.
These measures of premature death rely on populationbased mortality data and in many developed countries, national vital registration systems are the major source of such data. These systems provide universal coverage of the population and operate continuously; official notification to the registration office that a death has occurred is usually a legal requirement before burial or cremation can take place, and information about age at death, gender, place and time of death and cause of death is collected about each death and then collated centrally at population level. Once such data has been collated, surveillance of patterns of mortality data can take place.
Surveying patterns of mortality data is a reflexive process, identifying and responding to emerging trends and indicating where further analysis and action is required. Sutton (2012) 6 suggests that mortality surveillance should consist of two key elements. The first is the ongoing, systematic monitoring and analysis of mortality data. This requires that the entire population of a particular geographic area is included, and that the mortality data is accurate in terms of the characteristics of the people who have died and their causes of death. The second is that timely analysis of the data and dissemination of its findings will lead to actions being takeneither in relation to public health concerns raised by an understanding of the patterns of mortality, or in relation to the quality of the data itself.
Mortality data about people with ID
While information about the age and cause of death of the general population is routinely reported at national and cross-national levels, it is not usually possible to extract data about people with ID from this information. As a result, we know little at national and international levels about the age and cause of death of people with ID and are missing an are inappropriate for people with moderate and severe ID who are less likely to reach the age of 75 than those without ID (Patja et al. 2000) . In addition, life expectancy calculations can only be performed with confidence with population-years at risk of 5,000 or more (Williams et al. 2005) , and unless internationally comparable data is used, the small number of people with ID likely to be in some subgroups is problematic.
As most of the authors in this Special Edition indicate, using SMR provides a better measure of excess deaths in people with ID, although a comparatively small number of deaths of people with ID could give rise to a large amount of random variation, necessitating the aggregation of data over a number of years, or the combination of data from more than one geographic area.
Responding to the challenges faced
The challenge to obtain robust data about mortality of people with ID is considerable, but this Special Edition presents contributions from leading academics in a range of countries 11 about the data that is available in each country and how they are addressing the gaps in our knowledge about mortality of people with ID. We move from data relating to smaller geographical areas, through to national studies, and then to overviews of multiple studies within the same country. that although caution should be used when comparing the results of the studies, taken together they suggest that the life expectancy of people with ID has increased during the last two decades even though it remains below the life expectancy of the general population, gender-specific differences appear to be less significant than in the general population, and the severity of ID seems to be a strong influential factor in life expectancy.
In Germany, to-date, there has been very little or no empirical research about the life expectancy and mortality of people with ID. Germany has a particular age profile of people with ID because of the systematic killing of disabled people, including people with ID, in the Nazi era. As a result, the number of people with ID of retirement age in Germany is relatively small, and they are likely to be fairly resilientor The authors report an overall mortality rate in people with ID of 8.35%, but that this depended on age and severity of ID.
Overall mortality in people with ID was four times higher than in the general population, and they were, on average, dying 19 years earlier than peers in the general population. In the youngest age group mortality was almost seven times higher in the ID population than the general population but this decreased with increasing age. The overall SMR for females was larger than for males, but gender differences diminished with increasing age. The average age at death was lowest for those with profound ID and increased with decreasing severity of ID.
The authors suggest that between 2001 and 2003 there had been an increase in average age at death of approximately nine years and that although the increase had been sustained over the following decade, no further increases were noted during that time period. Some of the initial apparent improvements are likely to have been due to improved case finding, particularly of people with milder ID who are more likely to live longer lives. However, greater efforts are needs to more fully understand this pattern and the actions needed to sustain improvements in the life expectancy of people with ID.
The final two papers in this Special Edition provide overviews of a number of different studies within the same country. We start with a paper about mortality of people with ID in England by Heslop & Glover. They present the findings from four very different, recent sources of data about mortality of people with ID in England.
From piecing this information together, and reanalysing some data in the light of information provided by another of the data sources, the authors draw conclusions that are similar to those of the other studies already reported in this Special Edition: that people with ID have a reduced life expectancy of 13-20 years in England when compared with the general population, and that the differences are greatest for women (compared with women in the general population) and for those with the most severe ID (compared with people with mild ID), although people with mild ID also died significantly younger than people in the general population.
The SMRs of people with ID were twice that of the general population in England, and there was little indication of any reduction in this over time.
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The authors comment that although each of the data sources contributes some information, none provide comprehensive national data about mortality of people with ID that is able to take account of the age and sex distribution of the population. Such data is currently lacking in England, but is urgently needed in order to better monitor the mortality of people with ID and the impact of any actions that are being taken to address the health inequalities faced by this population. In England, the most promising way forward will be to link data from GP registers of people with ID with national mortality data held by the Office for National Statistics but to-date, delays over the past two years have not yet seen this initiative come to fruition. improved. The study of mortality in the general population has moved far beyond the examination of demographic factors through innovative new models and methods to improve our understanding of sources of health risk and pathways through which health outcomes can be improved (Rogers & Crimmins) . Without better mortality information, the people with ID are unlikely to benefit from these methods and we may continue to struggle with little reliable evidence of health and social inequities. It is imperative that disability researchers and public health departments work together to improve access to and the quality of mortality information to facilitate monitoring of this population.
The collection also focuses our intention, as ultimately, what we are working towards is the availability of evidence that will lead to measures being introduced to reduce premature and avoidable deaths in people with ID and ultimately improve the health of the population. It is this ambition that acts as the driver for much of the work being undertaken. It is also the hope of this group that the information and methodologies presented in this collection may serve as a model for other countries to begin or improve their mortality surveillance of people with ID.
